首页 > 最新文献

Asian Bioethics Review最新文献

英文 中文
Editorial Expression of Concern: National Regulation on Processing Data for Scientific Research Purposes and Biobanking Activities: Reflections on the Experience in Austria 编辑表达关注:关于为科学研究目的和生物银行活动处理数据的国家法规:对奥地利经验的反思。
IF 1.3 Q3 ETHICS Pub Date : 2024-12-09 DOI: 10.1007/s41649-024-00346-w
Joanna Osiejewicz, Dmytro M. Zherlitsyn, Svitlana M. Zadorozhna, Oleksii V. Tavolzhanskyi, Maryna O. Dei
{"title":"Editorial Expression of Concern: National Regulation on Processing Data for Scientific Research Purposes and Biobanking Activities: Reflections on the Experience in Austria","authors":"Joanna Osiejewicz, Dmytro M. Zherlitsyn, Svitlana M. Zadorozhna, Oleksii V. Tavolzhanskyi, Maryna O. Dei","doi":"10.1007/s41649-024-00346-w","DOIUrl":"10.1007/s41649-024-00346-w","url":null,"abstract":"","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 1","pages":"225 - 226"},"PeriodicalIF":1.3,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11785826/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonscientific Members of Institutional Review Boards 机构审查委员会的非科学成员。
IF 1.1 Q3 ETHICS Pub Date : 2024-12-07 DOI: 10.1007/s41649-024-00319-z
Joshua Cedric A. Gundayao, Julia Patrick Engkasan, Sharon Kaur

Given ICH-GCP’s role in shaping IRB standards in most jurisdictions, clarifying the function and definition of nonscientific members is crucial. ICH-GCP 3.2.1 requires a nonscientific member but its definition focuses on who they are not rather than who they are, creating ambiguity and varied interpretations. This paper reviews the idea of nonscientific members of the IRB to understand their definitions and roles based on current literature. This is because, despite the ICH-GCP’s mandate, recent research is scarce. Our review identifies that in the current literature, various definitions and roles are ascribed to nonscientific members, resulting in a lack of clarity. Following our thematic analysis, we highlight two main interpretations of the nonscientific member’s definition: one as a distinct perspective from scientific members and another as an embodiment of “ordinariness” to minimize bias. In addition, we also highlight three primary roles: reviewing consent forms, representing public and participant interests, and providing oversight. Some findings may not align with current IRB practices, and without clear definitions, adherence to ICH-GCP guidelines may be inconsistent.

鉴于ICH-GCP在制定大多数司法管辖区的IRB标准方面的作用,澄清非科学成员的功能和定义至关重要。ICH-GCP 3.2.1要求非科学成员,但其定义侧重于他们不是谁,而不是他们是谁,这造成了歧义和各种解释。本文在文献综述的基础上,回顾了非科学委员的概念,以了解他们的定义和角色。这是因为,尽管ICH-GCP的授权,最近的研究是稀缺的。我们的回顾发现,在目前的文献中,各种定义和角色被归因于非科学成员,导致缺乏清晰度。在我们的专题分析之后,我们强调了对非科学成员定义的两种主要解释:一种是来自科学成员的独特视角,另一种是“平凡”的体现,以尽量减少偏见。此外,我们还强调了三个主要作用:审查同意书,代表公众和参与者的利益,以及提供监督。一些发现可能与当前的IRB实践不一致,并且没有明确的定义,遵守ICH-GCP指南可能不一致。
{"title":"Nonscientific Members of Institutional Review Boards","authors":"Joshua Cedric A. Gundayao,&nbsp;Julia Patrick Engkasan,&nbsp;Sharon Kaur","doi":"10.1007/s41649-024-00319-z","DOIUrl":"10.1007/s41649-024-00319-z","url":null,"abstract":"<div><p>Given ICH-GCP’s role in shaping IRB standards in most jurisdictions, clarifying the function and definition of nonscientific members is crucial. ICH-GCP 3.2.1 requires a nonscientific member but its definition focuses on who they are not rather than who they are, creating ambiguity and varied interpretations. This paper reviews the idea of nonscientific members of the IRB to understand their definitions and roles based on current literature. This is because, despite the ICH-GCP’s mandate, recent research is scarce. Our review identifies that in the current literature, various definitions and roles are ascribed to nonscientific members, resulting in a lack of clarity. Following our thematic analysis, we highlight two main interpretations of the nonscientific member’s definition: one as a distinct perspective from scientific members and another as an embodiment of “ordinariness” to minimize bias. In addition, we also highlight three primary roles: reviewing consent forms, representing public and participant interests, and providing oversight. Some findings may not align with current IRB practices, and without clear definitions, adherence to ICH-GCP guidelines may be inconsistent.\u0000</p></div>","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 3","pages":"615 - 630"},"PeriodicalIF":1.1,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144754755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Understanding COVID‑19 Vaccine Hesitancy among the General Population in Japan from Public Health Ethical Perspectives: Findings from a Narrative Review 更正:从公共卫生伦理角度理解日本普通人群中的COVID - 19疫苗犹豫:来自叙述性综述的发现
IF 1.1 Q3 ETHICS Pub Date : 2024-12-04 DOI: 10.1007/s41649-024-00345-x
Moe Kuroda, Md Koushik Ahmed, Kaku Kuroda, Sandra D. Lane
{"title":"Correction to: Understanding COVID‑19 Vaccine Hesitancy among the General Population in Japan from Public Health Ethical Perspectives: Findings from a Narrative Review","authors":"Moe Kuroda,&nbsp;Md Koushik Ahmed,&nbsp;Kaku Kuroda,&nbsp;Sandra D. Lane","doi":"10.1007/s41649-024-00345-x","DOIUrl":"10.1007/s41649-024-00345-x","url":null,"abstract":"","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 4","pages":"767 - 768"},"PeriodicalIF":1.1,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s41649-024-00345-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145236889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
It is Not Time to Kick Out Radiologists 现在不是开除放射科医生的时候。
IF 1.3 Q3 ETHICS Pub Date : 2024-12-03 DOI: 10.1007/s41649-024-00325-1
Yuta Nakamura, Yuki Sonoda, Yosuke Yamagishi, Tomohiro Kikuchi, Takahiro Nakao, Soichiro Miki, Shouhei Hanaoka, Takeharu Yoshikawa, Osamu Abe
{"title":"It is Not Time to Kick Out Radiologists","authors":"Yuta Nakamura,&nbsp;Yuki Sonoda,&nbsp;Yosuke Yamagishi,&nbsp;Tomohiro Kikuchi,&nbsp;Takahiro Nakao,&nbsp;Soichiro Miki,&nbsp;Shouhei Hanaoka,&nbsp;Takeharu Yoshikawa,&nbsp;Osamu Abe","doi":"10.1007/s41649-024-00325-1","DOIUrl":"10.1007/s41649-024-00325-1","url":null,"abstract":"","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 1","pages":"9 - 15"},"PeriodicalIF":1.3,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11785856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is it Permissible to use Human Eggs in In-vitro Fertilization Training Courses? Insights from Islamic Scholarship 是否允许在体外受精培训课程中使用人类卵子?伊斯兰学者的见解。
IF 1.1 Q3 ETHICS Pub Date : 2024-12-02 DOI: 10.1007/s41649-024-00317-1
Saleem Ali Banihani

The utilization of in-vitro fertilization (IVF) in assisted reproduction has undergone a notable surge since its inception in 1979. Consequently, the demand for well-trained IVF personnel has become crucial to address the expanding technical requirements of this field. However, acquiring specialized technical expertise remains a challenge in various regions and countries, particularly in the Arab Islamic region, frequently playing a pivotal role in the successful implementation of medical technology. Ensuring a proficient workforce of IVF experts requires the provision of practical and comprehensive training opportunities. This work reveals the ethical considerations surrounding the utilization of actual human eggs in IVF training courses and examines potential alternative approaches to meet the training needs in a manner deemed ethically acceptable. We analyzed the bioethical issues of using human eggs in IVF training, considering ethical principles, benefits, and concerns to determine permissibility and contribute to discussions on reproductive technology ethics and the responsible use of human reproductive material. In addition, we shed light on perspectives from Islamic scholarship. In conclusion, utilizing immature eggs in practical IVF training, while ensuring informed consent, is widely deemed acceptable within the ethical framework. However, the crucial necessity of robust oversight, especially in the private sector, cannot be overstated. To address these critical considerations, the initial and fundamental step entails conducting a comprehensive regional survey. Using immature eggs in IVF training seems acceptable, but it is crucial to establish an oversight practice. Organizing a collaborative workshop with stakeholders from both the public and private sectors is a crucial first step in developing this controlled practice.

体外受精(IVF)在辅助生殖中的应用自1979年开始以来经历了显着的激增。因此,对训练有素的试管婴儿人员的需求已成为解决这一领域不断扩大的技术要求的关键。然而,在各个区域和国家,特别是在阿拉伯伊斯兰区域,获取专门技术知识仍然是一项挑战,往往在成功实施医疗技术方面发挥着关键作用。确保试管婴儿专家的熟练劳动力需要提供实用和全面的培训机会。这项工作揭示了围绕在试管婴儿培训课程中使用实际人类卵子的伦理考虑,并研究了以道德上可接受的方式满足培训需求的潜在替代方法。我们分析了在体外受精训练中使用人类卵子的生物伦理问题,考虑了伦理原则、利益和关注点,以确定是否允许,并为生殖技术伦理和人类生殖材料的负责任使用的讨论做出贡献。此外,我们还阐明了伊斯兰学术的观点。总之,在确保知情同意的情况下,在实际的试管婴儿训练中使用未成熟的卵子,在伦理框架内被广泛认为是可以接受的。然而,加强监管的关键必要性,尤其是在私营部门,怎么强调都不为过。为了解决这些关键问题,最初和根本的步骤需要进行全面的区域调查。在试管婴儿训练中使用未成熟的卵子似乎是可以接受的,但建立监督实践是至关重要的。与公共和私营部门的利益攸关方组织一次合作讲习班是发展这种受控做法的关键第一步。
{"title":"Is it Permissible to use Human Eggs in In-vitro Fertilization Training Courses? Insights from Islamic Scholarship","authors":"Saleem Ali Banihani","doi":"10.1007/s41649-024-00317-1","DOIUrl":"10.1007/s41649-024-00317-1","url":null,"abstract":"<div><p>The utilization of in-vitro fertilization (IVF) in assisted reproduction has undergone a notable surge since its inception in 1979. Consequently, the demand for well-trained IVF personnel has become crucial to address the expanding technical requirements of this field. However, acquiring specialized technical expertise remains a challenge in various regions and countries, particularly in the Arab Islamic region, frequently playing a pivotal role in the successful implementation of medical technology. Ensuring a proficient workforce of IVF experts requires the provision of practical and comprehensive training opportunities. This work reveals the ethical considerations surrounding the utilization of actual human eggs in IVF training courses and examines potential alternative approaches to meet the training needs in a manner deemed ethically acceptable. We analyzed the bioethical issues of using human eggs in IVF training, considering ethical principles, benefits, and concerns to determine permissibility and contribute to discussions on reproductive technology ethics and the responsible use of human reproductive material. In addition, we shed light on perspectives from Islamic scholarship. In conclusion, utilizing immature eggs in practical IVF training, while ensuring informed consent, is widely deemed acceptable within the ethical framework. However, the crucial necessity of robust oversight, especially in the private sector, cannot be overstated. To address these critical considerations, the initial and fundamental step entails conducting a comprehensive regional survey. Using immature eggs in IVF training seems acceptable, but it is crucial to establish an oversight practice. Organizing a collaborative workshop with stakeholders from both the public and private sectors is a crucial first step in developing this controlled practice.</p></div>","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 3","pages":"571 - 581"},"PeriodicalIF":1.1,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144754751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Permissibility of Biased AI in a Biased World: An Ethical Analysis of AI for Screening and Referrals for Diabetic Retinopathy in Singapore 在有偏见的世界中允许有偏见的人工智能:新加坡对糖尿病视网膜病变筛查和转诊的人工智能的伦理分析。
IF 1.3 Q3 ETHICS Pub Date : 2024-10-31 DOI: 10.1007/s41649-024-00315-3
Kathryn Muyskens, Angela Ballantyne, Julian Savulescu, Harisan Unais Nasir, Anantharaman Muralidharan

A significant and important ethical tension in resource allocation and public health ethics is between utility and equity. We explore this tension between utility and equity in the context of health AI through an examination of a diagnostic AI screening tool for diabetic retinopathy developed by a team of researchers at Duke-NUS in Singapore. While this tool was found to be effective, it was not equally effective across every ethnic group in Singapore, being less effective for the minority Malay population than for the Chinese majority. We discuss the problematic normative nature of bias in health AI and explore the ways in which bias can interact with various forms of social inequalities. From there, we examine the specifics of the diabetic retinopathy case and weigh up specific trade-offs between utility and equity. Ultimately, we conclude that it is ethically permissible to prioritise utility over equity where certain criteria hold. Given that any medical AI is more likely than not to have lingering bias due to bias in the training data that may reflect other social inequalities, we argue that it is permissible to implement an AI tool with residual bias where: (1) its introduction reduces the influence of biases (even if overall inequality is worsened), and/or (2) where the utility gained is significant enough and shared across groups (even if unevenly).

在资源配置和公共卫生伦理中,效用与公平是一个重要的伦理矛盾。我们通过检查由新加坡杜克大学-新加坡国立大学的一个研究小组开发的糖尿病视网膜病变人工智能诊断筛查工具,探讨了健康人工智能背景下效用与公平之间的紧张关系。虽然这个工具被发现是有效的,但它并不是对新加坡的每个种族都同样有效,对少数民族马来人的效果不如对多数民族的华人。我们讨论了健康人工智能中偏见的规范性问题,并探讨了偏见与各种形式的社会不平等相互作用的方式。从那里,我们检查糖尿病视网膜病变病例的具体情况,并权衡效用和公平之间的具体权衡。最终,我们得出结论,在某些标准成立的情况下,在道德上允许将效用优先于公平。鉴于任何医疗人工智能都更有可能由于可能反映其他社会不平等的训练数据中的偏差而存在持续偏差,我们认为允许在以下情况下实现带有残余偏差的人工智能工具:(1)它的引入减少了偏差的影响(即使总体不平等恶化),和/或(2)获得的效用足够显著并在群体之间共享(即使不均匀)。
{"title":"The Permissibility of Biased AI in a Biased World: An Ethical Analysis of AI for Screening and Referrals for Diabetic Retinopathy in Singapore","authors":"Kathryn Muyskens,&nbsp;Angela Ballantyne,&nbsp;Julian Savulescu,&nbsp;Harisan Unais Nasir,&nbsp;Anantharaman Muralidharan","doi":"10.1007/s41649-024-00315-3","DOIUrl":"10.1007/s41649-024-00315-3","url":null,"abstract":"<div><p>A significant and important ethical tension in resource allocation and public health ethics is between utility and equity. We explore this tension between utility and equity in the context of health AI through an examination of a diagnostic AI screening tool for diabetic retinopathy developed by a team of researchers at Duke-NUS in Singapore. While this tool was found to be effective, it was not equally effective across every ethnic group in Singapore, being less effective for the minority Malay population than for the Chinese majority. We discuss the problematic normative nature of bias in health AI and explore the ways in which bias can interact with various forms of social inequalities. From there, we examine the specifics of the diabetic retinopathy case and weigh up specific trade-offs between utility and equity. Ultimately, we conclude that it is ethically permissible to prioritise utility over equity where certain criteria hold. Given that any medical AI is more likely than not to have lingering bias due to bias in the training data that may reflect other social inequalities, we argue that it is permissible to implement an AI tool with residual bias where: (1) its introduction reduces the influence of biases (even if overall inequality is worsened), and/or (2) where the utility gained is significant enough and shared across groups (even if unevenly).</p></div>","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 1","pages":"167 - 185"},"PeriodicalIF":1.3,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11785882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Partial Disclosure in Research: Challenges, Justifications, and Recommendations for Ethical Oversight 探索研究中的部分披露:伦理监督的挑战、理由和建议。
IF 1.3 Q3 ETHICS Pub Date : 2024-10-30 DOI: 10.1007/s41649-024-00311-7
Ifeanyichukwu Akuma, Vina Vaswani

Deception in research is contentious, as ethical codes stress informed consent, yet complete disclosure may jeopardise validity. Indian Council for Medical Research (ICMR) guidelines classify deception into active, incomplete, and authorised forms. This study explores the ethical justification for incomplete (partial disclosure), permissible instances, and the dilemma faced by ethics committees in balancing scientific rigour and participant protection. The qualitative, non-experimental cross-sectional research, using in-depth interviews, identifies themes through thematic analysis. Findings reveal challenges for ethics committees, as incomplete information hampers understanding, amongst others. The paper proposes an ethics committee framework, urging researchers to minimise or avoid partial deception and recommending institutional awareness campaigns and standard operating procedures for minimal-harm studies using partial disclosure. Therefore, it proposes that partial disclosure should be justified by the 3Vs—value, validity, and veracity to preserve research integrity.

研究中的欺骗是有争议的,因为伦理准则强调知情同意,但完全披露可能危及有效性。印度医学研究委员会(ICMR)的指导方针将欺骗分为主动、不完整和授权三种形式。本研究探讨了不完全(部分)披露的伦理理由、允许的情况,以及伦理委员会在平衡科学严谨性和参与者保护方面面临的困境。定性的,非实验的横断面研究,使用深度访谈,通过主题分析确定主题。调查结果揭示了伦理委员会面临的挑战,因为不完整的信息阻碍了理解等。这篇论文提出了一个伦理委员会框架,敦促科学家尽量减少或避免部分欺骗,并建议为使用部分披露的危害最小的研究开展机构宣传活动和标准操作程序。因此,本文建议应通过3v -value、validity和veracity来证明部分披露的合理性,以保持研究的完整性。
{"title":"Exploring Partial Disclosure in Research: Challenges, Justifications, and Recommendations for Ethical Oversight","authors":"Ifeanyichukwu Akuma,&nbsp;Vina Vaswani","doi":"10.1007/s41649-024-00311-7","DOIUrl":"10.1007/s41649-024-00311-7","url":null,"abstract":"<div><p>Deception in research is contentious, as ethical codes stress informed consent, yet complete disclosure may jeopardise validity. Indian Council for Medical Research (ICMR) guidelines classify deception into active, incomplete, and authorised forms. This study explores the ethical justification for incomplete (partial disclosure), permissible instances, and the dilemma faced by ethics committees in balancing scientific rigour and participant protection. The qualitative, non-experimental cross-sectional research, using in-depth interviews, identifies themes through thematic analysis. Findings reveal challenges for ethics committees, as incomplete information hampers understanding, amongst others. The paper proposes an ethics committee framework, urging researchers to minimise or avoid partial deception and recommending institutional awareness campaigns and standard operating procedures for minimal-harm studies using partial disclosure. Therefore, it proposes that partial disclosure should be justified by the 3Vs—value, validity, and veracity to preserve research integrity.</p></div>","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 1","pages":"21 - 41"},"PeriodicalIF":1.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11785864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding COVID-19 Vaccine Hesitancy among the General Population in Japan from Public Health Ethical Perspectives: Findings from a Narrative Review 从公共卫生伦理角度理解日本普通人群中COVID-19疫苗犹豫:一项叙述性综述的结果
IF 1.3 Q3 ETHICS Pub Date : 2024-10-24 DOI: 10.1007/s41649-024-00310-8
Moe Kuroda, Md Koushik Ahmed, Kaku Kuroda, Sandra D. Lane

Japan has been reported as a country with high levels of vaccine hesitancy. However, a lack of comprehensive reviews studying factors for vaccine hesitancy for the COVID-19 vaccines in the Japanese context from the perspective of ethical controversy exists. Using a narrative review method, we reviewed factors associated with vaccine hesitancy to the COVID-19 vaccines and examined issues related to ethical controversy among the Japanese population. Factors associated with vaccine hesitancy include concerns about vaccine safety, suspicion of vaccine inefficacy, mistrust of the government, and low perceived threat. Factors associated with vaccine acceptance include environmental factors, factors related to Japanese cultural values, including collectivism and social norms, and positive attitudes toward information provided by authorities. Unique backgrounds in Japan are historical events such as the anti-HPV vaccine campaigns, the accessible medical system fostering high expectations of zero risk, and cultural factors of caring social norms influencing vaccine acceptance. Ethical controversies arise from preferences and practices at the individual or national level around individual rights versus public health benefits. Healthcare professionals and public health experts should continue dialoguing with the critical mass, practitioners, and policymakers, considering the ethical dilemmas surrounding individual rights and public health benefits. Insights obtained from this study indicate the need to develop tailored strategies to enhance vaccine acceptance while respecting individual autonomy within the Japanese context.

据报道,日本是一个对疫苗犹豫不决的国家。然而,目前还缺乏从伦理争议的角度研究日本人对 COVID-19 疫苗犹豫不决的因素的全面综述。我们采用叙事回顾的方法,回顾了与 COVID-19 疫苗犹豫不决相关的因素,并研究了日本人群中与伦理争议相关的问题。与疫苗犹豫不决相关的因素包括对疫苗安全性的担忧、对疫苗无效的怀疑、对政府的不信任以及低感知威胁。与接受疫苗有关的因素包括环境因素、与日本文化价值观有关的因素(包括集体主义和社会规范)以及对当局提供的信息的积极态度。日本的独特背景是历史事件,如抗 HPV 疫苗运动、促进对零风险的高期望值的便捷医疗系统,以及影响疫苗接受度的关爱社会规范等文化因素。伦理争议源于个人或国家层面围绕个人权利与公共卫生利益的偏好和做法。医疗保健专业人员和公共卫生专家应继续与关键群体、从业人员和政策制定者对话,考虑围绕个人权利和公共卫生利益的伦理困境。从本研究中获得的启示表明,有必要制定有针对性的策略,在尊重个人自主权的同时提高日本人对疫苗的接受度。
{"title":"Understanding COVID-19 Vaccine Hesitancy among the General Population in Japan from Public Health Ethical Perspectives: Findings from a Narrative Review","authors":"Moe Kuroda,&nbsp;Md Koushik Ahmed,&nbsp;Kaku Kuroda,&nbsp;Sandra D. Lane","doi":"10.1007/s41649-024-00310-8","DOIUrl":"10.1007/s41649-024-00310-8","url":null,"abstract":"<div><p>Japan has been reported as a country with high levels of vaccine hesitancy. However, a lack of comprehensive reviews studying factors for vaccine hesitancy for the COVID-19 vaccines in the Japanese context from the perspective of ethical controversy exists. Using a narrative review method, we reviewed factors associated with vaccine hesitancy to the COVID-19 vaccines and examined issues related to ethical controversy among the Japanese population. Factors associated with vaccine hesitancy include concerns about vaccine safety, suspicion of vaccine inefficacy, mistrust of the government, and low perceived threat. Factors associated with vaccine acceptance include environmental factors, factors related to Japanese cultural values, including collectivism and social norms, and positive attitudes toward information provided by authorities. Unique backgrounds in Japan are historical events such as the anti-HPV vaccine campaigns, the accessible medical system fostering high expectations of zero risk, and cultural factors of caring social norms influencing vaccine acceptance. Ethical controversies arise from preferences and practices at the individual or national level around individual rights versus public health benefits. Healthcare professionals and public health experts should continue dialoguing with the critical mass, practitioners, and policymakers, considering the ethical dilemmas surrounding individual rights and public health benefits. Insights obtained from this study indicate the need to develop tailored strategies to enhance vaccine acceptance while respecting individual autonomy within the Japanese context.</p></div>","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 1","pages":"141 - 165"},"PeriodicalIF":1.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11785853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Triad Approach to Best Interests when Responding to Discharge Demands from Hospitalized Patients Lacking in Mental Capacity to Decide on Treatment 对缺乏决定治疗的精神能力的住院病人的出院要求作出反应时,三位一体的最佳利益方法。
IF 1.3 Q3 ETHICS Pub Date : 2024-10-23 DOI: 10.1007/s41649-024-00309-1
See Muah Lee, Nydia Camelia Mohd Rais, Gerard Porter

Hospitalized patients lacking the mental capacity to consent to treatment may demand to be discharged from the hospital against medical advice. Forced custody of these patients, including the use of restraints, may be required if the plan is to proceed with treatment. This raises ethical concerns with regard to depriving people of their liberty. The determination of the wishes and values of the patient and her best interests may sometimes vary, depending on the assessor or the clinical team entrusted to perform the evaluation. We therefore propose the following triad for clinicians when determining the best interests for this group of patients to ensure ethical and legal soundness as well as in providing consistency in approach. Firstly, the treatment should serve as a rescue response. Secondly, any restraint deployed must be proportionate with a foreseeable end. Her liberty and autonomy interests should be enhanced by the treatment. Thirdly, the patient’s family must be supportive. This paper analyzes the use of the triad approach on two clinical cases, both assessed as lacking in mental capacity to decide on treatment and insisting to be discharged. Using this approach, we could justify how the contrasting outcomes, one in which the voluntary discharge was acquiesced versus the other, which was not acquiesced, were reached. We also examine the compatibility of the triad approach with the obligations under the United Nations Convention on the Rights of Persons with Disabilities (UNCRPD).

没有精神能力同意治疗的住院病人可能会违背医嘱要求出院。如果计划继续治疗,可能需要对这些病人进行强制监护,包括使用强制手段。这就引起了有关剥夺人的自由的伦理问题。对病人的意愿和价值观及其最大利益的判断有时可能会有所不同,这取决于受托进行评估的评估员或临床小组。因此,我们建议临床医生在确定这类病人的最佳利益时采用以下三要素,以确保伦理和法律上的合理性以及方法上的一致性。首先,治疗应作为一种救援反应。其次,任何限制措施都必须与可预见的目的相称。病人的自由和自主权应通过治疗得到加强。第三,病人家属必须给予支持。本文分析了在两个临床病例中使用三要素方法的情况,这两个病例都被评估为缺乏决定治疗的精神能力,并坚持要求出院。利用这种方法,我们可以证明如何得出两种截然不同的结果,一种是默许病人自愿出院,另一种是不默许病人自愿出院。我们还研究了三位一体方法与《联合国残疾人权利公约》规定的义务的兼容性。
{"title":"A Triad Approach to Best Interests when Responding to Discharge Demands from Hospitalized Patients Lacking in Mental Capacity to Decide on Treatment","authors":"See Muah Lee,&nbsp;Nydia Camelia Mohd Rais,&nbsp;Gerard Porter","doi":"10.1007/s41649-024-00309-1","DOIUrl":"10.1007/s41649-024-00309-1","url":null,"abstract":"<div><p>Hospitalized patients lacking the mental capacity to consent to treatment may demand to be discharged from the hospital against medical advice. Forced custody of these patients, including the use of restraints, may be required if the plan is to proceed with treatment. This raises ethical concerns with regard to depriving people of their liberty. The determination of the wishes and values of the patient and her best interests may sometimes vary, depending on the assessor or the clinical team entrusted to perform the evaluation. We therefore propose the following triad for clinicians when determining the best interests for this group of patients to ensure ethical and legal soundness as well as in providing consistency in approach. Firstly, the treatment should serve as a rescue response. Secondly, any restraint deployed must be proportionate with a foreseeable end. Her liberty and autonomy interests should be enhanced by the treatment. Thirdly, the patient’s family must be supportive. This paper analyzes the use of the triad approach on two clinical cases, both assessed as lacking in mental capacity to decide on treatment and insisting to be discharged. Using this approach, we could justify how the contrasting outcomes, one in which the voluntary discharge was acquiesced versus the other, which was not acquiesced, were reached. We also examine the compatibility of the triad approach with the obligations under the United Nations Convention on the Rights of Persons with Disabilities (UNCRPD).\u0000</p></div>","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 1","pages":"129 - 139"},"PeriodicalIF":1.3,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determining Mental Capacity and Identifying Surrogates: The Need for Clearer Guidance on Medical Decision-Making in Malaysia 确定心理能力和识别替代品:马来西亚需要更明确的医疗决策指导。
IF 1.3 Q3 ETHICS Pub Date : 2024-09-23 DOI: 10.1007/s41649-024-00313-5
Mark Kiak Min Tan

The dilemmas and uncertainties related to determining mental capacity and surrogate decision-making are universally recognised as one of the most important concepts in the field of clinical ethics. In Malaysia, healthcare practitioners often find both determining decision-making capacity of patients, and identifying surrogate decision makers for incapacitated patients confusing. This paper explores the concepts of decision-making capacity and surrogate decision-making, identifying key components and associated principles such as substituted judgement and best interests. It reviews current provisions and guidances available in Malaysia that are related to these issues, including the Power of Attorney Act 1949 (revised 1990), Mental Health Act 2001, and various guidelines. It then highlights the challenges encountered in the local clinical setting due to the lack of specific legislation and clear guidance. Finally, this paper provides recommendations for improvements to address these issues in order to safeguard both the clinical practice of healthcare professionals and the rights of patients. These recommendations include the establishment of a regulatory framework with four main domains: clear and objective criteria for mental capacity assessment, provisions for advance decision-making while patients still possess mental capacity, a ladder or hierarchy of surrogate decision-makers, and provisions for appropriate surrogate decision-making standards, as well as the need for advocacy and awareness education among both the general public and healthcare professionals.

与确定心理能力和替代决策相关的困境和不确定性被普遍认为是临床伦理学领域最重要的概念之一。在马来西亚,医疗保健从业人员经常发现确定患者的决策能力,并为无行为能力的患者确定替代决策者令人困惑。本文探讨了决策能力和替代决策的概念,确定了关键组成部分和相关原则,如替代判断和最佳利益。报告审查了马来西亚与这些问题有关的现行规定和指导方针,包括《1949年授权法》(1990年修订)、《2001年精神卫生法》和各种指导方针。然后,它强调了由于缺乏具体的立法和明确的指导,在当地临床环境中遇到的挑战。最后,本文提供了改进建议,以解决这些问题,以保障医疗保健专业人员的临床实践和患者的权利。这些建议包括建立一个有四个主要领域的管理框架:精神能力评估的明确和客观标准,在患者仍有精神能力时预先作出决策的规定,替代决策者的阶梯或等级制度,适当的替代决策标准的规定,以及在公众和保健专业人员中进行宣传和认识教育的必要性。
{"title":"Determining Mental Capacity and Identifying Surrogates: The Need for Clearer Guidance on Medical Decision-Making in Malaysia","authors":"Mark Kiak Min Tan","doi":"10.1007/s41649-024-00313-5","DOIUrl":"10.1007/s41649-024-00313-5","url":null,"abstract":"<div><p>The dilemmas and uncertainties related to determining mental capacity and surrogate decision-making are universally recognised as one of the most important concepts in the field of clinical ethics. In Malaysia, healthcare practitioners often find both determining decision-making capacity of patients, and identifying surrogate decision makers for incapacitated patients confusing. This paper explores the concepts of decision-making capacity and surrogate decision-making, identifying key components and associated principles such as substituted judgement and best interests. It reviews current provisions and guidances available in Malaysia that are related to these issues, including the Power of Attorney Act 1949 (revised 1990), Mental Health Act 2001, and various guidelines. It then highlights the challenges encountered in the local clinical setting due to the lack of specific legislation and clear guidance. Finally, this paper provides recommendations for improvements to address these issues in order to safeguard both the clinical practice of healthcare professionals and the rights of patients. These recommendations include the establishment of a regulatory framework with four main domains: clear and objective criteria for mental capacity assessment, provisions for advance decision-making while patients still possess mental capacity, a ladder or hierarchy of surrogate decision-makers, and provisions for appropriate surrogate decision-making standards, as well as the need for advocacy and awareness education among both the general public and healthcare professionals.</p></div>","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 1","pages":"117 - 128"},"PeriodicalIF":1.3,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asian Bioethics Review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1